117 related articles for article (PubMed ID: 22389088)
1. Inflammatory mediators involved in the progression of the metabolic syndrome.
Ma K; Jin X; Liang X; Zhao Q; Zhang X
Diabetes Metab Res Rev; 2012 Jul; 28(5):388-94. PubMed ID: 22389088
[TBL] [Abstract][Full Text] [Related]
2. Role and function of macrophages in the metabolic syndrome.
Bhargava P; Lee CH
Biochem J; 2012 Mar; 442(2):253-62. PubMed ID: 22329799
[TBL] [Abstract][Full Text] [Related]
3. Periodontal disease as part of the insulin resistance syndrome in diabetic patients.
Nishimura F; Soga Y; Iwamoto Y; Kudo C; Murayama Y
J Int Acad Periodontol; 2005 Jan; 7(1):16-20. PubMed ID: 15736891
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic role of scavenger receptor CD36 in the metabolic syndrome and diabetes.
Kennedy DJ; Kashyap SR
Metab Syndr Relat Disord; 2011 Aug; 9(4):239-45. PubMed ID: 21428745
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic reticulum stress and inflammation in obesity and diabetes.
Hummasti S; Hotamisligil GS
Circ Res; 2010 Sep; 107(5):579-91. PubMed ID: 20814028
[TBL] [Abstract][Full Text] [Related]
6. Obesity and the metabolic syndrome.
Vega GL
Minerva Endocrinol; 2004 Jun; 29(2):47-54. PubMed ID: 15257255
[TBL] [Abstract][Full Text] [Related]
7. Inflammation markers as mediators of vasculo-endothelial dysfunction and atherosclerosis in the metabolic syndrome.
Rizvi AA
Chin Med J (Engl); 2007 Nov; 120(21):1918-24. PubMed ID: 18067768
[No Abstract] [Full Text] [Related]
8. Diabetes-accelerated atherosclerosis and inflammation.
Kanter JE; Averill MM; Leboeuf RC; Bornfeldt KE
Circ Res; 2008 Oct; 103(8):e116-7. PubMed ID: 18845812
[No Abstract] [Full Text] [Related]
9. The metabolic syndrome, diabetes and lung dysfunction.
Tiengo A; Fadini GP; Avogaro A
Diabetes Metab; 2008 Nov; 34(5):447-54. PubMed ID: 18829364
[TBL] [Abstract][Full Text] [Related]
10. The role of cytokines in non-alcoholic steatohepatitis. A review.
Copaci I; Micu L; Voiculescu M
J Gastrointestin Liver Dis; 2006 Dec; 15(4):363-73. PubMed ID: 17205149
[TBL] [Abstract][Full Text] [Related]
11. Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels.
Liang KW; Lee WJ; Lee WL; Chen YT; Ting CT; Sheu WH
Clin Chim Acta; 2008 Feb; 388(1-2):41-5. PubMed ID: 17967444
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
[TBL] [Abstract][Full Text] [Related]
13. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
[TBL] [Abstract][Full Text] [Related]
14. Adipokines in diabetes and cardiovascular diseases.
Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
16. The progression of cardiovascular risk to cardiovascular disease.
Rosin BL
Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
[TBL] [Abstract][Full Text] [Related]
17. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
Wisse BE
J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
[TBL] [Abstract][Full Text] [Related]
18. A personalized approach to metabolic aspects of obesity.
Brietzke SA
Mt Sinai J Med; 2010; 77(5):499-510. PubMed ID: 20960552
[TBL] [Abstract][Full Text] [Related]
19. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans.
Leitinger N
Subcell Biochem; 2008; 49():325-50. PubMed ID: 18751917
[TBL] [Abstract][Full Text] [Related]
20. Adipose tissue macrophages.
Zeyda M; Stulnig TM
Immunol Lett; 2007 Oct; 112(2):61-7. PubMed ID: 17719095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
